Summary
Nimbus Therapeutics
Founded in 2009
Description
We integrate computational chemistry and other advanced technologies to design breakthrough medicines and transform drug development. https://t.co/zqoYVj2BW1
Strengths
- Nimbus Therapeutics has a strong market share in their industry
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Nimbus Therapeutics was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
Annual Revenue
Nimbus Therapeutics's annual revenue
$16907000
Based on Kona Equity data
-
Revenue per employee
$211338
-
Variance of revenue growth
0.01
-
Annual revenue growth since founding
$1127133
-
Revenue growth rate from first known quarter to current
5.8%
Employee Count
80 employees
-
Employee growth rate from first known quarter to current
50.0%
Executives
Tom Mclean
IP Counsel
t**@nimbustx.comMarcia Heron
Director, Program Management
m**@nimbustx.comBeth Browning
Scientist, Biology
b**@nimbustx.comPeter Tummino
Chief Scientific Officer
p**@nimbustx.comDwight Kim
Patent Counsel
d**@nimbustx.comScott Edmondson
Senior Vice President, Head of Chemistry
s**@nimbustx.comDebra Brennan
Senior Director, Structural Biology and BioPhysics
d**@nimbustx.comYuet Khong
Director, Drug Product Development
y**@nimbustx.comZak Huang
Vice President, Regulatory Affairs
z**@nimbustx.comXiaohua Zhu
Director, DMPK
x**@nimbustx.comHolly Whittemore
Chief Financial Officer
h**@nimbustx.comAngela Toms
Director, Structural Biology and Protein Sciences
a**@nimbustx.comErin Cowhig
Chief People Officer
e**@nimbustx.comMark Cartwright
Senior Vice President, Nonclinical
m**@nimbustx.comWes Westlin
Vice President, Preclinical Research & Early Development
w**@nimbustx.comAbbas Kazimi
Chief Business Officer
a**@nimbustx.comChristine Loh
Senior Vice President, Biology
c**@nimbustx.comGabrielle Poirier
Vice President, Clinical Operations
g**@nimbustx.comIan Sanderson
Chief Financial Officer
i**@nimbustx.comDerun Li
Senior Director, Medicinal Chemistry
d**@nimbustx.comKathleen Findlen
Consulting Director, Clinical Operations
k**@nimbustx.comAjay Upadhyay
Vice President, Early Clinical Development
a**@nimbustx.comJeb Keiper
CEO
j**@nimbustx.comSamantha Webb
Talent Associate Director, Recruitment
s**@nimbustx.comAvinash Phadke
Vice President, CMC
a**@nimbustx.comSheetal Kumar
In Vitro Scientist
s**@nimbustx.comRebecca Carazza
Executive Head of Information Systems, Director
r**@nimbustx.comPhone Therapeutics
Chief Executive Officer
p**@nimbustx.comJohn Hanna
Senior Director, Lead, Drug Safety
j**@nimbustx.comScott Cowen
Director
s**@nimbustx.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
1.45 M
-
Daily time
0:47
-
Bounce Rate
54.6 %
Location
Unlock unlimited leads
Similar Companies
ActivX Biosciences Inc
activx.com- Founded in 2000
- Location: La Jolla, CA
- Annual Revenue: $7.9M
- Employees: 33
- ActivX Biosciences is an emerging biopharmaceutical company that specializes in the discovery and development of highly selective, best-in-class, small molecule drugs for major unmet medical needs. With a focus on hematology, oncology, metabolic, and i...
International Therapeutics Inc
internationaltherapeutics.com- Founded in 1999
- Location: Seattle, WA
- Annual Revenue: $5.6M
- Employees: 25
- A privately held Seattle biotechnology company focused on the discovery and development of novel anti-viral therapies.
Karus Therapeutics
karustherapeutics.com- Location: Abingdon, Oxfordshire
- Annual Revenue: $4.8M
- Employees: 12
- Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.
Galecto
galecto.com- Founded in 2011
- Location: Copenhagen, MA
- Annual Revenue: $13.5M
- Employees: 40
- A Swedish company founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark.
Beauty and Propolis
tigrispharma.com- Founded in 2005
- Location: Bonita Springs, FL
- Annual Revenue: $5.9M
- Employees: 22
- Tigris Pharmaceuticals is a biopharmaceutical company developing therapeutic technologies for cancer and other unmet medical needs.
Ecrins Therapeutics
ecrins-therapeutics.com- Founded in 2010
- Location: La Tronche, Auvergne-Rhone-Alpes
- Annual Revenue: $1.5M
- Employees: 5
- A clinical-stage privately held #Biotech company specialized in the discovery and development of innovative drugs for use in human and #veterinary #oncology.
Key Information
- Name: Nimbus Therapeutics
- Industry: Biotechnology Company
- SIC: 87; 873
- NAICS: 5417; 541
See similar companies
-
By City Cambridge Small Biotechnology Company in Cambridge Mid-size Biotechnology Company in Cambridge
-
By State MA Small companies in MA Small Biotechnology Company in MA Mid-size Biotechnology Company in MA
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company
-
Firmographic data G Score of 6 Founded in 2009 SIC: 87 SIC: 873 NAICS: 5417 NAICS: 541 #Business Services General #Business Services
Frequently Asked Questions
Nimbus Therapeutics's headquarters are located at 130 Prospect St, Ste 301 STE 404 Cambridge, MA 02139.
Nimbus Therapeutics's official website is nimbustx.com
Nimbus Therapeutics's annual revenue is $16.9 M.
Nimbus Therapeutics's SIC: 87; 873
Nimbus Therapeutics's NAICS: 5417; 541.
Nimbus Therapeutics has 80 employees
